Mental health treatment is most effective when it reflects the individual—not just the diagnosis.
Psychotherapy is an important component of care for many psychiatric conditions, helping individuals develop healthier thought patterns, emotional regulation skills, and coping strategies. However, people with similar diagnoses often respond very differently to the same therapeutic approach.
At Neurotherapeutix, psychotherapy is integrated with fMRI-based computational brain mapping to better understand how each patient’s brain functions before treatment begins.
By combining neuroscience, advanced functional imaging, psychiatric expertise, and psychotherapy, our clinicians create individualized treatment plans designed around each person’s unique brain connectivity rather than relying on generalized treatment protocols.
This integrated model does not replace psychotherapy—it helps personalize it.
By understanding the neural circuits involved in a patient’s symptoms, clinicians can better align psychotherapy, psychiatric care, and fMRI-guided TMS therapy to support meaningful, lasting improvement.
Why psychotherapy alone sometimes falls short
Psychotherapy has transformed the lives of millions of people and remains a cornerstone of modern mental health care. Yet even when patients are highly motivated and actively engaged in treatment, progress can sometimes plateau.
One reason is that mental health conditions are influenced by far more than thoughts, behaviors, and life experiences. They are also shaped by the way different brain networks communicate with one another.
Two people may both be diagnosed with depression, anxiety, or another of the many mental health conditions treated at Neurotherapeutix. Yet, the underlying neural circuitry contributing to their symptoms may be very different. Those differences can influence how patients experience symptoms and how they respond to treatment.
For some individuals:
- Brain regions involved in mood regulation may communicate less efficiently.
- Networks responsible for attention, executive functioning, or emotional regulation may become disrupted.
- Functional connectivity between important brain circuits may be altered.
- Neural networks may become overactive, underactive, or poorly synchronized.
When these patterns exist, psychotherapy remains valuable, but the brain may need additional support before patients can fully benefit from the therapeutic process.
Rather than replacing psychotherapy, Neurotherapeutix seeks to strengthen the brain networks that therapy is designed to engage, creating a more personalized foundation for recovery.
What computational brain mapping reveals
Traditional brain imaging often focuses on anatomy—showing what the brain looks like. Computational brain mapping asks a different question:
How is the brain functioning?
At Neurotherapeutix, fMRI-based computational brain mapping evaluates resting-state functional connectivity (rsFC), enabling clinicians to examine how different brain regions communicate at rest.
Instead of simply identifying structural abnormalities, this process helps reveal patterns of communication between neural networks that may contribute to psychiatric or neurological symptoms.
Computational brain mapping allows clinicians to better understand:
- How brain regions interact as functional networks
- Which neural circuits appear overactive or underactive
- Whether communication between networks has become disrupted
- How these connectivity patterns may relate to an individual’s symptoms
Unlike standardized approaches that rely primarily on anatomical landmarks, Neurotherapeutix incorporates patented computational algorithms that analyze each patient’s unique functional connectivity before treatment planning begins.
This individualized process helps clinicians move beyond diagnosis alone. Rather than assuming every patient with depression, anxiety, or PTSD shares the same underlying brain activity, treatment planning begins with objective information about how that person’s brain networks function.
Research continues to demonstrate that combining functional MRI with transcranial magnetic stimulation allows clinicians to both measure and influence neural circuits associated with psychiatric symptoms, supporting a more personalized approach to care.
The result is a level of precision that helps clinicians develop treatment strategies tailored to each patient rather than applying identical protocols to every patient.
How computational brain mapping enhances psychotherapy
Psychotherapy helps individuals recognize patterns, develop coping strategies, process difficult experiences, and build healthier ways of thinking and responding.
Those psychological processes are supported by specific neural circuits within the brain.
When clinicians understand how those circuits are functioning before treatment begins, psychotherapy can become part of a broader, integrated care model that aligns psychological treatment with individualized neuroscience.
Rather than viewing psychotherapy and brain-based treatment as separate interventions, Neurotherapeutix integrates them into a coordinated treatment strategy.
Aligning stimulation with the circuits therapy targets
Psychotherapy and brain stimulation often work toward the same goal: strengthening healthier patterns of emotional regulation, cognition, and behavior.
Using fMRI-guided TMS therapy, clinicians can personalize stimulation based on the specific brain networks identified through computational brain mapping.
Instead of delivering stimulation to standardized anatomical locations, treatment targets are selected according to each patient’s functional connectivity.
This targeted approach helps ensure that brain stimulation supports many of the same neural circuits that patients are actively working to strengthen during psychotherapy.
Emerging research suggests that combining transcranial magnetic stimulation with therapeutic interventions may enhance clinical outcomes by improving the brain’s capacity for learning, emotional regulation, and adaptive change.
For patients, this means psychotherapy is not replaced by technology. Instead, advanced neuroscience helps create conditions that may make therapy even more effective.
Identifying the right target for the right patient
One of the defining principles of precision psychiatry is recognizing that no two brains function exactly alike.
Even individuals with the same diagnosis often demonstrate different patterns of functional connectivity, symptom presentation, treatment history, and recovery goals.
Computational brain mapping allows Neurotherapeutix clinicians to:
- Identify individualized treatment targets rather than relying on generalized assumptions
- Evaluate functional brain networks before treatment begins
- Personalize TMS targeting based on each patient’s unique connectivity
- Monitor clinical progress and adjust treatment recommendations as appropriate
This personalized approach represents an important evolution beyond traditional protocol-driven care.
Instead of asking, “What treatment works for this diagnosis?” Neurotherapeutix asks, “What treatment is most appropriate for this individual brain?”
That distinction lies at the heart of personalized neuroscience-guided mental health care.
What makes Neurotherapeutix’s approach different?
Many practices offer psychotherapy. Many offer TMS therapy. Some provide advanced brain imaging.
Neurotherapeutix brings these disciplines together through a fully integrated model of care centered on patented computational brain mapping and individualized treatment planning.
As the only clinical practice in the United States offering patented fMRI-guided computational brain mapping for TMS therapy, Neurotherapeutix has helped pioneer a precision-based approach to psychiatric and neurological care.
Rather than relying on standardized treatment protocols, our clinicians evaluate each patient’s unique functional brain connectivity before determining where to deliver stimulation.
This patented methodology is the result of years of scientific research and innovation led by Dr. Alayar Kangarlu and Dr. Marta Moreno. The underlying technology includes patented computational brain mapping methods, bringing advanced neuroscience directly into clinical practice. Before developing Neurotherapeutix’s patented technology, Dr. Alayar Kangarlu and Dr. Marta Moreno conducted cutting-edge research at Columbia University combining neuroimaging and brain-stimulation techniques.
This individualized approach also reflects the growing field of precision psychiatry, which recognizes that patients sharing the same diagnosis may have very different patterns of brain network activity and therefore may benefit from different treatment strategies. Rather than treating a diagnosis alone, Neurotherapeutix develops treatment plans based on each patient’s symptoms, clinical history, functional brain connectivity, and treatment goals.
When psychotherapy, psychiatry, advanced functional imaging, and personalized TMS therapy are coordinated within a single treatment plan, every component of care works toward the same objective: improving the function of the neural circuits underlying each individual’s symptoms.
The Neurotherapeutix integrated care model
At Neurotherapeutix, treatment is designed as a coordinated process rather than a series of separate appointments.
Each patient’s care plan is individualized, with every step building upon the information gathered during the previous phase. This collaborative approach allows clinicians to continuously evaluate progress and make thoughtful adjustments as treatment evolves.
Patients typically move through a structured care pathway that includes:
- Comprehensive psychiatric evaluation
- Functional brain imaging and computational brain mapping
- Personalized fMRI-guided TMS treatment planning
- Integration with psychiatric services
- Ongoing monitoring and individualized treatment adjustments
Because these services are coordinated within one multidisciplinary team, communication remains consistent throughout treatment.
Psychiatric evaluations, psychotherapy, functional imaging, and brain stimulation all inform one another, creating a more comprehensive understanding of each patient’s progress over time.
Who benefits from this integrated approach?
Combining computational brain mapping with psychotherapy may be particularly beneficial for individuals who:
- Have not experienced sufficient improvement with psychotherapy or medication alone
- Are seeking a more personalized approach to mental health care
- Have previously completed standard TMS therapy without achieving the desired results
- Are managing conditions associated with disrupted functional brain connectivity
This integrated model is frequently used for individuals living with:
- Depression
- Anxiety
- PTSD
- dOCD
It may also be beneficial for those living with other neurological and psychiatric conditions where individualized treatment planning may help optimize care.
Instead of focusing solely on symptom reduction, Neurotherapeutix seeks to better understand the neural networks underlying each person’s condition, enabling treatment to be tailored accordingly.
Frequently asked questions
Does computational brain mapping replace psychotherapy at Neurotherapeutix?
No. Psychotherapy can be an important part of care for many patients. Computational brain mapping is designed to complement psychotherapy by helping clinicians better understand the brain networks associated with a patient’s symptoms, enabling more personalized treatment.
How does fMRI-guided TMS therapy complement psychotherapy?
Psychotherapy focuses on developing healthier patterns of thinking, emotional regulation, and behavior, while fMRI-guided TMS therapy supports the brain networks involved in these processes.
Neurotherapeutix combines individualized, fMRI-guided brain stimulation with the broader goals of a patient’s psychotherapy and clinical care.
By targeting brain networks associated with a patient’s symptoms, fMRI-guided TMS may support the cognitive and emotional processes important for therapeutic progress. This personalized approach may promote greater cognitive flexibility, insight, attention, emotional regulation, and the capacity to set and pursue meaningful short- and long-term goals.
fMRI-guided TMS is designed to complement—not replace—psychotherapy and other elements of a comprehensive treatment plan.
Is fMRI-based computational brain mapping safe?
Yes. Functional MRI is a non-invasive imaging technique that does not use ionizing radiation. When performed in an appropriate clinical setting, fMRI has a well-established safety profile and can provide valuable information about brain activity and functional connectivity to support individualized treatment planning.
What conditions benefit most from combining computational brain mapping with therapy?
This integrated approach may benefit individuals experiencing depression, anxiety disorders, PTSD, obsessive-compulsive disorder (OCD), traumatic brain injury, and other neurological or psychiatric conditions where disruptions in functional brain connectivity may contribute to symptoms.
Every treatment plan is individualized following a comprehensive clinical evaluation.
How is Neurotherapeutix different from other TMS therapy clinics?
Neurotherapeutix is the only clinical practice in the United States offering patented computational brain mapping to personalize fMRI-guided TMS therapy.
Rather than relying solely on standardized anatomical landmarks, clinicians evaluate each patient’s functional brain connectivity before determining individualized treatment targets.
This precision-based approach reflects years of scientific research and innovation and is a key distinction from conventional TMS treatment models.
Patients can also learn more about personalized TMS vs. standard TMS to better understand how individualized targeting differs from traditional approaches.
What research supports combining fMRI-based computational brain mapping with psychotherapy?
An expanding body of scientific literature suggests that combining advanced functional brain imaging, individualized brain stimulation, and evidence-based psychotherapy may improve understanding of the neural circuits involved in mental health disorders and support more personalized treatment planning.
Research has demonstrated that functional MRI can help identify brain networks associated with psychiatric symptoms, while transcranial magnetic stimulation can modulate those same networks.
Additional studies suggest that pairing TMS with therapeutic interventions may enhance clinical outcomes by supporting neuroplasticity and improving the brain’s capacity for adaptive change.
At Neurotherapeutix, these scientific advances are translated into clinical practice through patented computational brain mapping, individualized TMS targeting, and integrated psychiatric and psychotherapeutic care designed around each patient’s unique brain connectivity.
Take the next step toward personalized mental health care
Mental health care continues to evolve as neuroscience provides new ways to understand how the brain functions.
By combining psychotherapy with patented computational brain mapping, advanced functional imaging, psychiatric expertise, and personalized TMS therapy, Neurotherapeutix offers an individualized approach tailored to each patient’s unique brain—not just their diagnosis.
If you’re interested in learning more about how it works or exploring whether this integrated approach may be appropriate for you or a loved one, we invite you to request an appointment with our multidisciplinary team.
